Remus Pharmaceuticals Limited — Others, 23-06-2025: Shareholders meeting

Remus Pharmaceuticals Limited has announced the approval of an issue of bonus shares to its shareholders through a Postal Ballot, which passed with overwhelming support, securing 100% votes in favor from those who participated (52.14% voting turnout). The promoters and promoter group, holding a significant portion of shares, supported the resolution fully. This move enhances shareholder value by increasing equity base without impacting cash reserves, indicating the company's confidence in its financial position and growth prospects.